Volume 88 Issue 25 | pp. 22-23
Issue Date: June 21, 2010

Drug Safety Reform

Recall of children's medicine prompts lawmakers to consider new authorities, resources for FDA
Department: Government & Policy
Keywords: unsafe products, FDA, recalled medicine

When McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, recalled more than 40 types of widely used children’s medicine on April 30, confidence in the safety of the U.S. drug supply took a nose dive. American consumers and members of Congress, already wary of the quality of imported medicine, began questioning whether drugs manufactured in the U.S. are any better than those made overseas.

As J&J tries to rebuild its . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society